Furthermore, the effects of the recipient genotypes on the development and treatment outcome of SOS/VOD were unclear, although previous reports [26,27] have suggested an association of a low ADAMTS13 activity with the development of SOS/VOD. This evidence concerns the gene ADAMTS13 and spondylo-ocular syndrome.